North RUN Strategic Opportunities Fund I, LP

Director North RUN Strategic Opportunities Fund I, LP sold 3,571,400 shares of LPTH at $14.00 for $49,999,600 on 2026-06-03; retains 2,934,828 shares plus derivative holdings.

North RUN Strategic Opportunities Fund I, LP, a director of LIGHTPATH TECHNOLOGIES, sold 3,571,400 (3.57M) shares at $14.00 on 2026-06-03, representing a -54.9% reduction in non-derivative holdings while retaining 2,934,828 shares plus 6,493 shares of Series G Convertible Preferred Stock. The sale occurred at a price significantly below the current market price of $17.62 and the 52-week high of $18.94, suggesting the trade was executed at a discount to recent valuations. Examining timing patterns: the insider's prior five sales at LPTH each generated positive 90-day returns (ranging from +21.2% to +30.7%), meaning the stock rose after each prior sale—a pattern of poorly-timed exits at this ticker. This current sale at $14.00, occurring as LPTH trades near 52-week highs following a +45.6% 30-day rally and +59.2% 90-day surge, stands in contrast to the insider's prior same-ticker execution. The company remains unprofitable on a full-year basis despite +17.3% annual revenue growth, adding uncertainty to whether recent price appreciation is sustainable.

North RUN Strategic Opportunities Fund I, LP sells 293,052 shares at $12.21 blended avg; still holds 2.99M shares post-transaction.

North RUN Strategic Opportunities Fund I, LP (Director) executed a three-day sale of 293,052 shares totaling $3,576,837.00 at a blended average price of $12.21, near the current price of $12.15 but significantly below the 52-week high of $16.53. The timing is noteworthy given that the insider's prior trades at LPTH have shown poor 90-day timing—only 1 of 5 prior sells at this ticker were well-timed (negative 90-day returns), while the most recent four sales between 2026-03-17 and 2026-03-25 all posted positive 90-day returns, meaning the stock rose after those sales. The company is unprofitable with net income of $-4,106,287.00 despite 17.3% annual revenue growth, and the stock has declined 15.0% over the past 30 days and is -26.5% from its 52-week high, suggesting a period of weakness. The director retains a substantial 2.99M share position post-transaction.

Fund director sold 356,909 shares for $4.4M (avg $12.27); stock now at $10.99, -23.3% from 52-week high.

North Run Strategic Opportunities Fund I, LP (Director) executed 2 separate sales totaling 356,909 shares for $4,379,910.54, with per-transaction prices of $12.06 and $12.31 respectively on consecutive days (2026-03-24 and 2026-03-25). The holder retains 3,283,164 shares post-transaction, a 9.8% reduction from pre-transaction holdings. The sale occurred at the blended average price of $12.27, but the current price of $10.99 represents a -23.3% discount from the 52-week high, and the stock has declined 8.3% over the trailing 30 days despite a 21.8% gain over 90 days. LPTH is unprofitable (full-year net income negative at $-9,405,409.00), though it shows strong revenue growth of 17.3% year-over-year on a $16,351,652.00 quarterly base. The transaction reflects a conditional reduction in exposure during a period of elevated valuation relative to recent price peaks, though derivative holdings per Form 4 Table II are not yet populated in the database, so the reported shares_after may not reflect the full economic position.

Director North Run Fund sold 120,454 shares ($1.4M) at $12.01 avg on Mar 17-18; still holds 2.90M shares.

North Run Strategic Opportunities Fund I, LP sold 104,454 shares at $12.01 on 2026-03-17 and 16,000 shares at $12.00 on 2026-03-18, totaling 120,454 shares for $1,446,492.54, reducing holdings by 4.0% to 2,900,073 shares. The blended average transaction price of $12.01 exceeds the current price of $11.49 by approximately 4.5%, indicating the sales occurred near a relative peak. The fund's cross-ticker track record shows 9 prior sells with an average 30-day return of -19.8%, suggesting a mixed historical pattern, though outcomes at LPTH remain unmeasurable as five consecutive prior sells at this ticker all occurred within the past two weeks. LPTH itself remains unprofitable with net income of $-9,405,409.00 on quarterly revenue of $16,351,652.00, despite annual revenue growth of 17.3%, providing context for monitoring executive capital allocation in a growth-stage but cash-negative business.

North Run Strategic Opportunities Fund I sold 674,995 shares ($8.2M) over 3 days at $12.03–$12.18; holds 3.02M shares post-sale

North Run Strategic Opportunities Fund I, a director at LightPath Technologies, executed 3 separate sales totaling 674,995 shares for $8,180,640.45 over March 2–4, 2026, at prices ranging from $12.03 to $12.18 per share (blended average $12.12). The sale reduced holdings by 18.3%, from 3,695,522 shares to 3,020,527 shares post-transaction. The sales occurred as the stock was trading -17.7% below its 52-week high of $14.33, but the shares liquidated just above the blended average of the 5 prior sells conducted on 2026-02-20, -02-23, -02-24, and -02-25. The fund's cross-ticker sell track record shows an average 30-day return of -19.8% following prior sales, though measurable outcome data for the same-ticker sales of February 20–25 is not yet available. LightPath is unprofitable (full-year net income -$9,405,409), though it posted quarterly revenue of $16,351,652 and annual revenue growth of +17.3%.

Fund Director sold 300,092 LPTH shares at $12.18, reducing stake 9.2%; stock now -27.2% from 52-week high at $10.43

North Run Strategic Opportunities Fund I, LP sold 300,092 shares of LIGHTPATH TECHNOLOGIES at $12.18 on 2026-02-25, reducing its stake from 3,255,614 to 2,955,522 shares. The sale occurred near the top of the stock's recent range — the transaction price of $12.18 sits only $2.15 below the 52-week high of $14.33, yet the stock has since fallen to $10.43 (currently -27.2% from its peak). This director's cross-ticker track record shows an average 30-day return of -19.8% following prior sells; however, timing assessment for the same ticker is limited, with only one measurable 30-day outcome at LPTH (a prior sell on 2026-01-05 with a -19.8% return). The company is unprofitable with a net income of $-9,405,409 in the latest quarter, though it reports annual revenue growth of 17.3%, creating tension between growth narrative and near-term loss position. This large reduction by an established fund investor merits attention to whether subsequent market movement reflects broader concerns about valuation or execution.

Director entity sells 733.4K shares at $12.43 avg; holds 3.26M post-sale amid unprofitable Q and stock -16.3% from peak

North Run Strategic Opportunities Fund I, LP (Director) executed 4 separate sales totaling 733,354 shares for $9,117,649.90 across February 20–24, 2026, at an average price of $12.43, reducing its LPTH position by 18.4% to 3,255,514 shares. The sales occurred as the company reported a net loss of $-9,405,409.00 in its latest quarter and remains unprofitable on a full-year basis, even as revenue grew 17.3% year-over-year. The current stock price of $11.99 sits 16.3% below the 52-week high and 3.6% lower over 30 days, suggesting the insider sold into relative strength before recent weakness materialized. The director retains substantial holdings (3.26M shares) post-transaction, indicating a partial reduction rather than a full position exit, and the prior trade at this ticker (January 5, 2026 sell) showed a 30-day decline of 19.8%, establishing a pattern of sales preceding or coinciding with stock deterioration.

Director North Run Strategic Opportunities Fund I sold 770,321 shares of LPTH at $11.72, reducing stake by 22.0% to 2,728,968 shares

North Run Strategic Opportunities Fund I, a director-level insider, executed a substantial sale of 770,321 shares at $11.72 on 2026-01-05, generating $9,028,162.12 and reducing total holdings from 3,499,289 shares to 2,728,968 shares. The sale occurred at a price near the 52-week high ($12.20), with the current price unchanged from that peak, while the stock has posted strong 30-day (+39.6%) and 90-day (+27.1%) gains. LPTH is unprofitable on a full-year basis (net income of $-2,893,002.00) despite recent revenue growth of 17.3%, creating a divergence between financial performance and stock momentum that warrants investor attention. The 22.0% reduction in insider holdings during a period of elevated price levels and rapid stock appreciation suggests a material reassessment of the director's position in the company.